The global Alosetron Market is a specialized segment within the gastrointestinal (GI) therapeutics industry, defined by its highly targeted patient demographic and rigorous safety protocols. Alosetron, a selective 5-HT3 receptor antagonist, is the primary pharmacological intervention for women with severe diarrhea-predominant irritable bowel syndrome (IBS-D) who have not responded to ...